Patient Satisfaction , Prosthetic Complications and Clinical Outcomes of PEEK Composite Versus Titanium Zirconium

Sponsor
Mansoura University (Other)
Overall Status
Completed
CT.gov ID
NCT06111391
Collaborator
(none)
30
1
2
11.6
2.6

Study Details

Study Description

Brief Summary

This study aimed to evaluate patient satisfaction (VAS) , prosthetic outcomes and clinical outcomes of polyether ether ketone (PEEK) Versus Titanium Zirconium fixed prostheses supported by six maxillary implants and opposed by distal extension removable partial denture.

Condition or Disease Intervention/Treatment Phase
  • Device: Osstell® device (Integration Diagnostics Ltd.).
N/A

Detailed Description

thirty patients were selected for this study from a previous study who have already received previous implants in the maxillary arch. The patients were divided into two groups: Group1 received maxillary titanium zirconium full arch fixed prosthesis and mandibular distal extension partial denture, Group 2 received maxillary PEEK composite full arch fixed prosthesis and mandibular distal extension partial denture Patient satisfaction was evaluated using visual analogue scale (VAS) after one year months , Prosthetic complications were measured on the patient and implant levels after one year

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Investigator)
Primary Purpose:
Treatment
Official Title:
Patient Satisfaction , Prosthetic Complication and Clinical Outcomes of PEEK Composite Versus Titanium Zirconium Maxillary Fixed Full Arch Prosthetic Opposing Mandibular Distal Extension Partial Denture
Actual Study Start Date :
Apr 15, 2022
Actual Primary Completion Date :
Mar 12, 2023
Actual Study Completion Date :
Apr 2, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: maxillary titanium zirconium full arch fixed prosthesis

maxillary titanium zirconium full arch fixed prosthesis and mandibular distal extension partial denture.

Device: Osstell® device (Integration Diagnostics Ltd.).
After trans-mucosal abutments were removed and the smart pegs were attached to the fixtures, resonance frequency analysis was done to assess implant stability.The implant stability quotient (ISQ) was used to quantify stability via the Osstell® device (Integration Diagnostics Ltd.).

Active Comparator: maxillary peek composite full arch fixed prosthesis

maxillary peek composite full arch fixed prosthesis and mandibular distal extension partial denture.

Device: Osstell® device (Integration Diagnostics Ltd.).
After trans-mucosal abutments were removed and the smart pegs were attached to the fixtures, resonance frequency analysis was done to assess implant stability.The implant stability quotient (ISQ) was used to quantify stability via the Osstell® device (Integration Diagnostics Ltd.).

Outcome Measures

Primary Outcome Measures

  1. implant stability [12 months]

    After transmucosal abutments were removed and the smart pegs were attached to the fixtures, resonance frequency analysis was done to assess implant stability.The implant stability quotient (ISQ) was used to quantify stability via the Osstell® device (Integration Diagnostics Ltd.).

Eligibility Criteria

Criteria

Ages Eligible for Study:
58 Years to 68 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

Normal jaw relation Good oral hygiene Patient with class I or class II inter-rach space in order to have sufficient restoration space to construct FP3 prosthesis.

Exclusion Criteria:

Patients with TMJ disorder and heavy smokers for more than 10 cigarettes per day.

Uncooperative patient. Unfavorable occlusion. Limited restoration space (less than 12 mm).

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mansoura university Mansoura Egypt 35516

Sponsors and Collaborators

  • Mansoura University

Investigators

  • Study Director: Marwa Aboelez, Phd, Mansoura University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Mansoura University
ClinicalTrials.gov Identifier:
NCT06111391
Other Study ID Numbers:
  • A27080622
First Posted:
Nov 1, 2023
Last Update Posted:
Nov 1, 2023
Last Verified:
Feb 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Nov 1, 2023